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Bone marrow-derived mesenchymal stem cells (BMDMSC) are emerging as a therapeutic modality in various inﬂammatory
disease states, including acute lung injury (ALI). A hallmark of inﬂammation, and a consistent observation in patients with ALI, is
a perturbation in the systemic redox environment. However, little is known about the eﬀects of BMDMSC on the systemic redox
status. The objective of the present study was to determine whether exogenously infused BMDMSC protect against endotoxin-
induced oxidation of plasma cysteine (Cys) and glutathione (GSH) redox states. To determine the eﬀect on the redox state if
BMDMSC, mice received endotoxin intraperitoneally (1mg/kg), followed by intravenous infusion of either 5 × 105 BMDMSC or
an equal volume of saline solution. Control mice received intraperitoneal endotoxin followed by 5 × 105 lung ﬁbroblasts given
intravenously. Cys, cystine (CySS), GSH, and glutathione disulﬁde (GSSG) concentrations were determined by HPLC. Results
showed sequential preservation of plasma Cys and GSH levels in response to BMDMSC infusion. The data show that BMDMSC
infusion leads to a more reducing Cys and GSH redox state. The ﬁndings are the ﬁrst to demonstrate that BMDMSC have
antioxidant eﬀects in vivo, and add to our understanding of the systemic eﬀects of BMDMSC in lung injury.
1.Introduction
The inﬂammatory response to pathogens, physical trauma,
or toxic stimuli is critical in host defense, but excessive
and unregulated inﬂammation can injure the lungs [1]. In
patients with gram negative sepsis, a disregulated inﬂamma-
tory response to bacterial endotoxin increases the risk for
acute lung injury (ALI), which can lead to severe respira-
tory failure termed the acute respiratory distress syndrome
(ARDS) [1]. ALI and ARDS are associated with signiﬁcant
morbidity and mortality [2]. Consequently, strategies to
attenuate the inﬂammatory response in ALI and ARDS are
of considerable interest.
An emerging therapeutic modality in various inﬂamma-
tory diseases is the use of bone marrow-derived mesenchy-
mal stem cells/mesenchymal stromal cells (BMDMSCs)
[3]. BMDMSCs are multipotent cells that can be isolated
from the bone marrow and expanded in culture relatively
easily. Several studies, including our own, have shown that
exogenously infused BMDMSCs protect against endotoxin-
induced inﬂammation, and ALI in mice [4–6]. In these
studies, the protective eﬀects of BMDMSCs are mediated by
a decrease in circulating proinﬂammatory cytokine levels,
and appear to be independent of BMDMSCs engraftment
into the lung. A hallmark of inﬂammation, and a consistent
observation in patients with ALI, is a perturbation in2 Stem Cells International
the extracellular thiol/disulﬁde redox environment. How-
ever, little is known about the eﬀects of BMDMSCs on the
systemic thiol/disulﬁde redox environment.
Cysteine (Cys) and its disulﬁde cystine (CySS), together
with glutathione (GSH) and glutathione disulﬁde (GSSG),
comprise the major extracellular thiol/disulﬁde redox con-
trol systems. Cys and GSH are important determinants
of cytokine expression, and alteration in Cys and GSH
metabolism is a central feature of inﬂammation [7]. Because
the thiol/disulﬁde redox environment is intimately linked
to inﬂammation and tissue injury, the present study was
undertaken to examine the eﬀects of exogenous BMDMSC
infusion on plasma Cys and GSH levels. Accumulating
evidence shows that the redox states of Cys and GSH are
independently regulated [8]; therefore a secondary purpose
was to determine whether the two redox couples respond
diﬀerently to BMDMSC infusion. Mice received endotoxin
intraperitoneally, followed by intravenous infusion of 5 ×
105, CD 45-immunodepleted BMDMSCs. Results showed
sequential preservation of plasma Cys and GSH redox
states in response to BMDMSC infusion. The data provide
the novel observation that BMDMSC infusion modulates
thiol/disulﬁde redox status in vivo.
2.MaterialsandMethods
2.1. Materials. Except as indicated, all chemicals were pur-
chased from Sigma Chemical Corporation (Sigma, St. Louis,
MO). Distilled, deionized water was used for analytical
purposes. HPLC quality solvents were used for HPLC.
2.2. Experimental Animals. Experiments were conducted
using 10–14-week-old, female C57BL/6J mice (Jackson Lab-
oratories, Bar Harbor, ME). Mice were housed in cages
and maintained on a 12-hour light-12-hour dark cycle at
the Division of Animal Resources at Emory University. All
animals were fed pelleted rodent food (Test Diet 5015, Lab
Diet Inc., Richmond, IN) and had free access to water. All
experiments were initiated during the light cycle. All animal
protocols were reviewed and approved by the Institutional
Animal Care and Use Committee. Because estrogens may
exert anti-inﬂammatory eﬀects, inﬂuence of estrous cycle
cannot be entirely ruled out in the current experiments
[9].
2.3. LPS Administration. Escherichia coli O55:B5 LPS, dis-
solved in sterile PBS, was administered intraperitoneally at
a dose of 1mg LPS/kg body weight. Mice were subsequently
anesthetized by isoﬂuorane inhalation (Baxter Pharmaceuti-
cals, Deerﬁeld, IL), and given 5 × 105 BMDMSC in 0.1mL
PBS, 5 × 105 primary lung ﬁbroblasts in 0.1mL PBS, or
0.1mL PBS. The retro-orbital vein was used for intravenous
administration. Studies by group have shown that BMDM-
SCs at this dose exert anti-inﬂammatory eﬀects in vivo [10].
Therefore, this dose was used to determine if BMDMSCs
also exert protective eﬀects on oxidative stress. Animals were
sacriﬁced at 2, 6, and 24hours postLPS administration. No
mortality was associated with LPS administration.
2.4. Sample Collection and Analysis of Cys, CySS, GSH, and
GSSG. Samples were collected using a method optimized to
minimize errors due to collection and processing [11]. Mice
were anesthetized by isoﬂuorane inhalation and blood was
collected by submandibular bleeding using a 4mm mouse-
bleeding lancet (Medipoint, Inc. Mineola, NY). To minimize
artiﬁcial overestimation of GSH due to hemolysis, blood was
collected into a heparin-coated eppendorf tube to inhibit
coagulation. Samples that showed evidence of hemolysis
were not included in the analysis.
The collected blood was (0.18mL) immediately trans-
ferred to an eppdendorf tube containing 0.02mL of preser-
vation solution. The preservation solution included hep-
arin, serine-borate to inhibit degradation of GSH by γ-
glutamyltranspeptidase, bathophenanthroline disulfonate to
inhibit oxidation of GSH and Cys, and iodoacetic acid to
alkylateGSHandCys.Tofacilitatequantiﬁcationofthethiols
and disulﬁdes, γ-glutamyl glutamate (γ-Glu-Glu) was used
as an internal standard [12]. Samples were centrifuged at
16000g for 60 seconds to remove precipitated protein, and
0.1mL of the supernatant was immediately transferred to an
equal volume of ice-cold 10% (w/v) perchloric acid. Samples
were immediately stored at −80
◦C and were derivatized with
dansyl chloride within 1 month. Stability tests have shown
that nonderivatized samples are stable for at least 2 months
at −80
◦C[ 11].
For HPLC analysis (Gilson Medical Electronics, Middle-
ton, WI), derivatized samples were centrifuged, and 35μl
of the aqueous layer was applied to the Supercosil LC-
NH2 column (25cm × 4.6mm; Supelco, Bellefunk, PA).
Derivatives were separated with a sodium acetate gradi-
ent in methanol/water and detected by ﬂuorescence [11].
Concentrations of thiols and disulﬁdes were determined by
integrationrelativetotheinternalstandard.Redoxstates(Eh)
of the GSH/GSSG, and Cys/CySS pools, given in millivolts
(mV), were calculated from concentrations of GSH, GSSG
and Cys, CySS in molar units with the following forms
of the Nernst equation for pH 7.4:GSH/GSSG, Eh =
−264 + 30 log ([GSSG]/[GSH]
2), Cys/CySS, Eh =− 250 +
30log ([CySS]/[Cys]
2)[ 13].
2.5. Cell Culture. Cells were maintained in a humidiﬁed
5% CO2 incubator at 37
◦C. A frozen vial of murine bone
marrow-derived mesenchymal stem cells, obtained from the
Tulane Center for Gene Therapy, New Orleans, Louisiana,
was thawed and expanded as previously described [14].
BMDMSCs were propagated in a 175cm2 ﬂask in Iscove’s
modiﬁed Dulbeccos’s medium (IMDM) containing 9% fetal
bovine serum (FBS, Atlanta, Biologicals, Norcross, GA), 9%
horse serum, and 1% penicillin-streptomycin Cells were
harvested at 70% conﬂuency using 0.25% trypsin. Harvested
cells were depleted of contaminating hematopoietic cells by
magnetic immunodepletion with anti-CD45 conjugated to
phycoerythrin (PE), followed by PE-conjugated magnetic
beads (Miltenyi Biotec, Auburn, CA). After negative deple-
tion, plastic-adherent cells were propagated for upto 10
passages. For in vivo infusion, cells were detached using
0.25%trypsinat37
◦Cfor5minutes. Trypsin wasneutralizedStem Cells International 3
by adding IMDM with serum. The cell suspension was
centrifuged and resuspended in sterile PBS (without Ca
and Mg). After two additional washes with PBS, cells were
counted by trypan blue exclusion and were resuspended at
5 ×105 cells per 0.1mL of PBS.
Primary ﬁbroblasts were isolated from the lungs of 8–10-
week-old wild type C57BL/6J mice, as previously described
[15]. Cells were maintained in DMEM supplemented with
10% FBS and 1% penicillin-streptomycin (MediaTech, Man-
assas, VA) for up to 10 passages. For in vivo infusion, cells
were harvested and processed as described above. Passage
number of BMDMSC and primary ﬁbroblasts was similar
in all animals for all time points within each experimental
replicate.
2.6. Cytokine Analysis. Levels of IL-1β, TNF-a, and IFN-y in
plasma were detected by ELISA (R&D Systems, Minneapolis,
MN).
2.7. Flow Cytometry. Flow cytometry for expression of a
panel of surface markers was performed on a FACScan
cytometer (Becton Dickinson) using standard techniques.
BMDMSCs were harvested by trypsinization, washed in
PBS, and stained with the following antibodies:Fluorescein
isothiocyanate- (FITC-) anti-CD45, PE-anti-CD11b, and
PerCP-Cy5.5-anti-Sca-1(PharmigenSanJose,CA).Acquired
data were analyzed using FlowJo software (Tree Star, San
Carlos, CA).
2.8.DiﬀerentiationAssays. TheabilityofBMDMSCtodiﬀer-
entiate into multiple mesenchymal lineages was determined
using a mesenchymal stem cell functional identiﬁcation kit
(R&D Systems Minneapolis, MN USA). Adipogenic diﬀer-
entiation was induced by seeding cells for 14 days in α-MEM
medium with 10% FBS, 1% penicillin-streptomycin, and
adipogenic supplement containing hydrocortisone, isobutyl-
methylxanthine, and indomethacin. Oil droplets in the
cultures were identiﬁed by staining cells with Oil Red O.
Osteogenic diﬀerentiation was induced by culturing cells for
21 days in α-MEM medium with 10% FBS, 1% penicillin-
streptomycin, and osteogenic supplement containing dex-
amethasone, ascorbate-phosphate, and β-glycerolphosphate.
The calcium containing precipitates were visualized after
staining with 2% Alizarin red adjusted to a pH of 4.4 with
ammonium hydroxide. Chondrogenic diﬀerentiation was
induced by pelleting cells in a 6-well plate and culturing in
D-MEM/F-12 with 1% penicillin-streptomycin, and chon-
drogenic supplement containing dexamethasone, ascorbate-
phosphate,proline,pyruvate,andTGF-β3.Pelletedcellswere
cultured for 14 days and stained with Alcian blue to visualize
acid mucopolysachharides.
2.9. Statistical Methods. Data are presented as means +
SEM from 4–6 animals. Statistical analysis was done using
Graph Pad Prism v 4.01. A one-tailed, unpaired t-test was
used to compare the LPS/BMDMSC group to LPS/Saline
and LPS/Fibroblast groups at each of given time points.
Signiﬁcance was set at a P value <. 05.
3. Results
3.1. Characterization of Bone Marrow-Derived Mesenchymal
Stem Cells. Enrichment of bone marrow-derived mesenchy-
mal stem cells from crude bone marrow suspensions is
achieved by selection for a plastic-adherent population that
expresses neither hematopoietic nor endothelial cell surface
markers but is positive for the expression of adhesion and
stromal markers [3]. However, because a deﬁned panel
of unambiguous markers distinguishing MSC is lacking,
a gold standard criterion for establishing MSC phenotype
is a trilineage diﬀerentiation assay where the plasticity of
MSC is conﬁrmed by their ability to diﬀerentiate into
adipocytes, osteocytes, and chondrocytes, on stimulation
[16].
In the present study, we conﬁrmed MSC phenotype
by ﬂow cytometry analysis and by diﬀerentiation assays.
Analysis by ﬂow cytometry demonstrated that the cells were
uniformly negative for the hematopoietic markers, CD11b
and CD45 (blue, BMDMSC). Cells stained positive for
Stem cell antigen (Sca)-1 (Figures 1(a)–1(c)). Diﬀerentiation
assays demonstrated that BMDMSCs retained their ability to
diﬀerentiate into adipocytes, osteocytes, and chondrocytes
f o ru pt o1 0p a s s a g e s( F i g u r e s1(d)–1(e)). Thus, the cell
population used in the present study represents a phenotype
that is consistent with MSC.
3.2. Eﬀect of BMDMSC Infusion on Endotoxin-Induced In-
ﬂammatory Response. We have previously reported that
BMDMSC infusion attenuates the systemic inﬂammatory
response to endotoxin [4]. In present study, we deter-
mined the eﬀect of BMDMSC infusion on a select panel
of pro-inﬂammatory cytokines to conﬁrm that the anti-
inﬂammatory eﬀect of BMDMSC infusion was independent
of LPS serotype administered (O55:B5 in the present study
versusO111:B6in[17]).ResponsesinLPS/BMDMSCgroup
were compared to LPS/Saline group.
Plasma levels of TNF-α (Figure 2(a)), IFN-γ
(Figure 2(b)), and IL-1β (Figure 2(c)) were determined at 2
hours, 6 hours, and 24 hours postendotoxin administration.
Cytokine levels in Saline/BMDMSC group ranged from
being non-detectable to < 20pg/mL at all time points and
are not shown for clarity.
Consistent with previous observations, results showed
that BMDMSC infusion attenuated the acute inﬂammatory
response to endotoxin. A signiﬁcant decrease in plasma
TNF-α levels was observed at 2hours (Figure 2(a) (pg/mL);
LPS/Saline, 360 ± 53; LPS/BMDMSC, 103.2 ± 19.2; P<. 01)
and 6hours (LPS/Saline, 75 ± 28.2; LPS/BMDMSC, 32 ± 5;
P<. 05). Evaluation of plasma IFN-γ levels revealed a 5-
fold decrease with BMDMSC infusion at 6h (Figure 2(b)
(pg/mL);LPS/Saline,166.7 ± 24.1;LPS/BMDMSC,29 ± 8.3;
P<. 001).
Measurement of IL-1β levels demonstrated a 1.7-fold
decrease in response to BMDMSC infusion at 2hours
(Figure 2(c)(pg/ml);LPS/Saline,76. 4 ± 10;LPS/BMDMSC,
43 ± 10.2; P<. 05) and a 2-fold decrease at 6h (LPS/Saline,
68.6 ± 10.3; LPS/BMDMSC, 33.2 ± 4.6; P<. 01). The















































Figure 1: Characterization of BMDMSC by ﬂow cytometry and diﬀerentiation capacity. Flow cytometry of BMDMSC demonstrated that cells
did not express the hematopoietic markers, CD11b and CD45 ((a)-(b); blue; BMDMSC; grey; isotype control, red; alveolar macrophages).
BMDMSC stained positive for Sca-1 ((c); blue; BMDMSC; grey; isotype control). In (d)–(f), cells were examined for diﬀerentiation capacity.
Fat droplets in cell preparations incubated in adipogenic medium for 14 days were stained with Oil Red O (d). Cells incubated with
osteogenic medium for 21 days were stained Alizarin red to detect Calcium (e). Cartilage pellets were stained with Alcian blue to detect
mucopolysachharides, after 14 days in chondrogenic medium (f).
group conﬁrms the anti-inﬂammatory eﬀects of BMDMSC
in vivo.
3.3. Eﬀect of BMDMSC Infusion on Endotoxin-Induced Deple-
tion of Plasma GSH and Oxidation of GSH/GSSG Redox State.
Having established that BMDMSC infusion induced anti-
inﬂammatory eﬀects in vivo, we next determined whether
BMDMSC infusion was also associated with protection
from perturbations in plasma GSH redox state. Because
lung ﬁbroblasts represent a primary, stromal-cell population
originating from mesenchymal precursors, animals injected
with LPS/Lung ﬁbroblasts served as a second set of controls
for these analyses.
In previous studies we have found that endotoxin-
induced weight loss occurs due to a decrease in food intake
[7], and decreased food intake is an important determinant
of plasma GSH and Cys levels [18]. In the present study,
we determined loss in body weight 24hours posttreatment
in LPS/Saline group versus LPS/BMDMSC group. Mice
receiving intraperitoneal saline followed by intravenous
BMDMSC served as controls. As shown in Figure 3,m i c e
treated with Saline/BMDMSC did not show a signiﬁcant
decline in body weight (body weight (g); 0hours, 19.5 ±
0.6; 24hours, 19.2 ± 0.6). As expected, LPS/Saline-treated
animals lost a signiﬁcant amount of body weight (0hours,
20.3 ± 0.5; 24hours, 18 ± 0.6; P<. 0 5 ) .H o w e v e r ,b o d y
weight did not signiﬁcantly decrease in mice treated with
LPS/BMDMSC (0hours, 21 ± 0.9; 24hours, 19 ± 0.7; P =
.05), suggesting protection due to BMDMSC infusion. It
must be noted however that the eﬀects of BMDMSCs on
body weight are unlikely to be clinically signiﬁcant.
The dynamics of plasma GSH and Cys in response to
endotoxin is previously described by our group [17]. In
contrast to the sustained oxidation of GSH and Cys redox
states until 24–48hours that we previously reported; the
present experiments show recovery of these thiol/disulﬁde
couples by 24hours. These diﬀerences can be ascribed to
serotype diﬀerences in LPS. However, we cannot exclude the
possibility that these diﬀerences may have also resulted, in
part, from variations in the dose of endotoxic LPS delivered.
As seen in Figure 4(a), BMDMSC infusion had no eﬀect
on the acute decline in plasma GSH at 2hours (plasma GSH
(μM), Control, 24 ± 0.2; LPS/Saline, 19.3 ± 0.9( P<. 001);
LPS/BMDMSC, 20.8 ± 1.8), but protected against decline in
G S Hl e v e l sa t6h( L P S / S a l i n e ,2 2 .7 ± 1.1; LPS/BMDMSC,
26 ± 0.7; P<. 05), and 24hours (LPS/Saline, 23.4 ± 0.4;
LPS/BMDMSC, 26.8 ± 0.8; P<. 05). Measurement of GSH
levels in LPS/Lung ﬁbroblast group revealed that GSH levels
weresigniﬁcantlybelowLPS/BMDMSCgroupat6hoursand
24hours (LPS/Lung ﬁbroblast; 6hours, 19.2 ± 0.2; 24hours,
22.3 ± 0.7; P<. 01).
Plasma GSSG did not show signiﬁcant changes with
treatment (Figure 4(b)). Calculation of GSH redox state
using concentrations of GSH and GSSG revealed that
















































































Figure 2: Eﬀect of BMDMSC infusion on endotoxin-induced
inﬂammatory response. C57BL/6J mice were treated with 1mg/kg
i.p LPS followed by i.v infusion of either 500,000 BMDMSC
(LPS/BMDMSC), or 0.1mL Saline (LPS/Saline) alone. At 2hours,
6hours,and24hoursmiceweresacriﬁcedandplasmawascollected
for analysis of TNF-α (a), IFN-γ (b), and IL-1β (c). Data are
expressed as means+SEM. aValues in LPS/BMDMSC group signif-























Figure 3: Eﬀect of BMDMSC infusion on endotoxin-induced weight
loss. C57BL/6J mice were treated with 1mg/kg i.p LPS or with
saline. LPS-treated animals were either given intravenous Saline
(LPS/Saline) or BMDMSC (LPS/BMDMSC). Saline treated mice
were given intravenous BMDMSC. Body weight was measured at
0hours and 24hours post treatment.
reduced in LPS/BMDMSC group compared to LPS/Saline
and LPS/Lung ﬁbroblast group (Figure 4(c);E h GSH/GSSG
(mV), LPS/Saline, −139.2 ± 0.7; LPS/Lung ﬁbroblast,
−140.5 ±1;LPS/BMDMSC, −147.6 ±0.3;P<. 01).Thedata
show that BMDMSC protected against endotoxin-induced
oxidationofGSH/GSSGredoxstateat24hoursbyimproving
GSH homeostasis.
3.4. Eﬀect of BMDMSC Infusion on Endotoxin-Induced
Depletion of Plasma Cys and Oxidation of Cys/CySS Redox
State. Decrease in plasma Cys levels and oxidation of
Cys/CySS redox state is an early event in endotoxin-induced
ALI [7]. Results showed that BMDMSC infusion did not
protect against the acute decline in plasma Cys levels at
2hours(Figure 5(a); plasma Cys (μM),Control, 26.1 ± 0.08;
LPS/Saline, 12.4 ± 0.4; LPS/Lung ﬁbroblast, 11.8 ± 1.7;
LPS/BMDMSC, 9.8 ± 0.7; P<. 01 compared to controls).
Indeed, Cys levels in LPS/BMDMSC group were signiﬁcantly
lower than LPS/Saline group at 2hours (P<. 05). Despite
this early decline, plasma Cys levels started to recover in
LPS/BMDMSC treated group compared to LPS/Saline group
at 6hours (LPS/Saline, 9.1 ± 0.8; LPS/BMDMSC, 13.3 ±
1; P<. 05). Cys levels in LPS/Lung ﬁbroblast group also
increased (15.2 ± 0.3; P< 0.05 compared to LPS/Saline
group) and could not be distinguished from LPS/BMDMSC
group at 6hours. By 24hours Cys levels normalized in all
three treatment groups.
Plasma levels of the disulﬁde of Cys, CySS, increased
signiﬁcantly at 2hours with endotoxin treatment and was
not altered due to BMDMSC infusion (Figure 5(b); plasma
CySS (μM), Control, 64.2 ± 6.5; LPS/Saline, 122.2 ± 5.3;
LPS/BMDMSC, 118.2 ± 6.1; P<. 01 compared to controls).








































































Figure 4: Eﬀect of BMDMSC infusion on endotoxin-induced depletion of plasma GSH and oxidation of GSH/GSSG redox state. C57BL/6J
mice were treated with 1mg/kg i.p LPS followed by i.v infusion of either 500,000BMDMSC (LPS/BMDMSC), Lung ﬁbroblasts (LPS/Lung
ﬁbroblast), or 0.1mL Saline (LPS/Saline) alone. At 2hours, 6hours, and 24hours mice were sacriﬁced and plasma was collected for HPLC
analysis of GSH (a) and GSSG (b). Eh GSH/GSSG (c) was calculated from the GSH and GSSG concentrations using the Nernst equation.
Data are expressed as means+SEM. aValues in LPS/BMDMSC group signiﬁcantly diﬀerent from time-matched LPS/Saline group. bValues
in LPS/BMDMSC group signiﬁcantly diﬀerent from time-matched LPS/Lung ﬁbroblast group.
signiﬁcantly decreased at 2hours and increased at 6hours
prior to normalization at 24hours (LPS/Lung ﬁbroblast;
2hours,93.5 ± 5.3; 6hours, 115.2 ± 8.4; P<. 05 compared
to LPS/Saline and LPS/BMDMSC group).
Despite no changes in CySS, preservation of plasma Cys
by BMDMSC infusion resulted in Eh Cys/CySS being, on
average, 8mV more reduced, compared to LPS/Saline group
at 6hours (Figure 5(c); Eh Cys/CySS (mV), LPS/Saline,
−72.5 ± 3; LPS/BMDMSC, −80.6 ± 2.4; P<. 05). A similar
magnitude of protection in Eh Cys/CySS was also observed
in LPS/Lung ﬁbroblast group (−79 ± 1.5; P<. 05 compared
to LPS/Saline). Thus, the data show that BMDMSC infusion
resulted in a modest but signiﬁcant preservation of plasma
Cys and Eh Cys/CySS at 6hours. However, this eﬀect was
not speciﬁc because similar responses were observed in
the LPS/Lung ﬁbroblast group. Together, the combined
observations show that BMDMSC infusion resulted in
sequential preservation of Cys and GSH redox states at
6hoursand24hours,respectively .ThepreservationofGSH
was speciﬁc to BMDMSC infusion while Cys redox state was
preserved with BMDMSC and Lung ﬁbroblast infusion.
4. Discussion
The main ﬁnding of the present study is that infusion of
BMDMSCsisassociatedwithanincreaseinsystemicCysand
GSH levels, which results in the preservation of Cys and GSH
redox states during endotoxemia. These data are the ﬁrst,
to our knowledge, to demonstrate that BMDMSC infusion











































































treated with 1mg/kg i.p LPS followed by i.v infusion of either 500,000BMDMSC (LPS/BMDMSC), Lung ﬁbroblasts (LPS/Lung ﬁbroblast),
or0.1mLSaline(LPS/Saline)alone.At2hours,6hours,and24hoursmiceweresacriﬁcedandplasmawascollectedforHPLCanalysisofCys
(a) and CySS (b). In (c), Eh Cys/CySS was calculated from the Cys and CySS concentrations using the Nernst equation. Data are expressed
as means+SEM. aValues in LPS/BMDMSC group signiﬁcantly diﬀerent from time-matched LPS/Saline group. bValues in LPS/BMDMSC
group signiﬁcantly diﬀerent from time-matched LPS/Lung ﬁbroblast group.
Several lines of evidence indicate that the biological
thiol/disulﬁde redox environment dictates responses to
inﬂammatory stimuli. Experimental manipulation of Cys
and GSH levels alters cytokine production in vitro in
mononuclear cells and [19] alters lymphocyte activation
[20]. In vivo, oral pretreatment of mice with GSH and
N-acetyl cysteine (NAC) attenuates LPS-induced TNF-α in
the circulation and in the spleen [21]. Thus, Cys and GSH
are critical determinants of cytokine production during
activation of the immune system. However, in the present
study we observe that the decrease in TNF-α and IL-1β at
2hoursprecedestheincreaseinplasmaCysandGSHlevelsat
6hours.Thissuggeststhattheimprovedhomeostasisofthese
redox couples by BMDMSC infusion is not upstream to the
decrease in proinﬂammatory cytokine levels. Nonetheless,
because Cys and GSH redox systems are fundamental to
basic cellular processes such as proliferation, diﬀerentiation,
and apoptosis [22], the improvement in plasma Cys and
GSH indices may have therapeutic eﬀects in attenuating
lung injury and/or facilitating repair. Thus, preservation
of the thiol/disulﬁde redox environment may represent an
additional therapeutic eﬀect of BMDMSC infusion.
The potential mechanisms by which BMDMSC infusion
improves GSH homeostasis may involve increased eﬄux
of Cys and GSH from tissues, increased recycling, and/or
increased GSH synthesis. This can be mediated by the
secretion of soluble growth factors by BMDMSCs, or by
the interaction of BMDMSCs with host cells, or both. A
candidate growth factor likely responsible for the redox
modulatory eﬀect of BMDMSCs is keratinocyte growth8 Stem Cells International
factor (KGF). BMDMSCs constitutively produce KGF [23],
and studies in a murine model of allogenic bone marrow
transplantshowthatsubcutaneousinfusionofKGFimproves
hepatic GSH levels [24]. Because 50%–80% of plasma GSH
is dependent on eﬄux from the liver [25], increase in
hepatic GSH could increase plasma GSH levels. Additionally,
elevated levels of proinﬂammatory cytokines can adversely
impact GSH homeostasis. In pulmonary endothelial cells,
TNF-α decreases cellular GSH and increases GSSG levels
[26]. Thus, BMDMSC-mediated decrease in plasma TNF-α
and IL-1β levels at 2hours could also have led to improved
GSH homeostasis at subsequent time points.
While improved homeostasis of plasma GSH is observed
only in the BMDMSC group but not the lung ﬁbroblast
group, the dynamics of plasma Cys are similar in both
groups. This would suggest that the improvement in plasma
Cys is not a speciﬁc response BMDMSC infusion. Additional
studies comparing stromal cells such as MSCs and lung
ﬁbroblasts with cell types from epithelial and endothelial
lineages are needed to better delineate whether modula-
tion of Cys homeostasis in vivo is a cell-type dependent
or independent phenomenon. Nonetheless, because both
the Cys and GSH redox systems are intimately linked to
inﬂammation, repair, and regeneration, the preservation of
both these redox systems by BMDMSCs is therapeutically
signiﬁcant.
While the present observations are the ﬁrst to demon-
strate that BMDMSCs have redox modulatory eﬀects in
vivo, there is evidence supporting the antioxidant capacity
of MSCs. For instance, Kim and colleagues have demon-
strated that the antioxidant capacity of adipose tissue-
derived MSC conditioned medium (ADCM) is comparable
to 100μMa s c o r b i ca c i d[ 27]. Furthermore, culturing tert-
butyl hydroperoxide-treated dermal ﬁbroblasts with ADCM
improved cell viability, indicating that MSC-derived factors
protect against oxidative injury. This study suggests that
MSCs actively secrete antioxidant factors which may confer
protection in the setting of inﬂammatory lung diseases
such as ALI. However, studies in matrigel angiogenesis
assay have demonstrated that direct contact of MSCs with
endothelialcells(EC:MSCratio;1:1to1:3)ledtoincreased
ROS production resulting in endothelial cell apoptosis and
ultimately to capillary degeneration [28] .Ad r o pi nc y t o -
toxicity was observed when MSC numbers were decreased
by an order of magnitude. These studies indicate that in
vivo eﬀects of MSCs may vary, depending on the MSC
number and on the interacting cell population. Further
studies investigating the eﬀects of BMDMSC conditioned
media on thiol/disulﬁde redox state will provide greater
mechanistic insights into the action of BMDMSCs in
vivo.
In conclusion, the present study demonstrates that in a
murine model of endotoxin-induced inﬂammation, infusion
of syngeneic BMDMSCs improved plasma Cys and GSH
redox indices at 6h and 24hours, respectively. These studies
are the ﬁrst, to our knowledge, to demonstrate the antioxi-
dant eﬀects of BMDMSC in vivo. Further studies are needed
to investigate the mechanistic basis for the improvement of
thiol/disulﬁde redox status by BMDMSCs.
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